Industry has key role to play in COE anti-counterfeiting treaty

By Gareth Macdonald

- Last updated on GMT

Related tags: Pharmacology, Drug

The role of the pharma industry in supporting the COE anti-counterfeiting treaty, which aims to criminalise activities, “cannot be underestimated”, according to a directorate member.

Sabine Walser, a member of the Council of Europe’s directorate for the quality and safety of medicines and health, told in-PharmaTechnologist that cooperation between industry and authorities is important.

Industry has vast product knowledge, can raise awareness and ensure good practices in distribution, said Walser. These qualities give it a very important role in the fight against counterfeit drugs and the adoption and implementation of the Medicrime Convention.

The Medicrime Convention aims to promote cross-border cooperation between authorities and drive the criminalisation of activities relating to drug counterfeiting.

Related news

Show more

Related product

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

Related suppliers